Johnson & Johnson (J&J) has announced plans to spin off its Consumer Health unit from its Pharmaceutical and Medical Device business, creating two independent publicly traded companies.
Subject to approvals and meeting specific conditions, the separation is anticipated to conclude in 18 to 24 months.
Following the separation, the new J&J will continue to be a healthcare company with a sharpened focus on key areas with unmet medical needs and leverage innovation and technology in the biopharmaceutical and medical device sectors to expand the standard of care.
